Tuberculosis Paediatrics
Conditions
Interventions
Spirometry
Sponsors
Glaxosmithkline
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Children from 6 years up to 19 years who have been diagnosed with TB.
Exclusion criteria
Exclusion criteria: 1. Children with any preexisting lung disease eg. Asthma 2. Children younger than 6 years of age. Children younger than 6 years of age may have difficulty performing spirometry. 3. Children diagnosed with extra pulmonary TB 4. Caregivers who at time of inclusion know that their children cannot be followed for the next 18 months. For instance, if the caregiver is planning to travel and cannot come back for a follow up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study will therefore provide a detailed description of lung damage for pulmonary TB after treatment. The expected findings from the study will estimate the burden of and characterize post-TB lung disease in the paediatric population. The study will provide evidence that can lead to changes in policy on post-TB lung disease management strategies. | — |
Secondary
| Measure | Time frame |
|---|---|
| Will determine the associated factors, including clinical and anthropometric factors, affecting impaired lung function as assessed by spirometry of children being treated for TB and after completing pulmonary TB treatment. | — |
Countries
Ghana
Contacts
Public ContactChristodea Haizel
Project Manager
Outcome results
None listed